$11.32
-0.07-0.61%
Last update: Oct 12, 7:56 PM
$11.25
-0.14-1.23%
Zevra Therapeutics Inc
ZVRANASDAQ
Zevra Therapeutics (ZVRA) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $0.14 | $0.08 | $0.05 | $-0.03 |
| Actual | $0.25 | $0.18 | $0.19 | $-0.01 |
| Surprise | +78.6% | +125.0% | +280.0% | +66.7% |
| Revenue | ||||
| Estimate | $33.6M | $31.8M | $28.0M | $26.6M |
| Actual | $39.7M | $36.2M | $34.1M | $26.1M |
| Surprise | +18.1% | +13.8% | +21.9% | -2.01% |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $0.17 | $0.19 | $0.20 | $0.25 |
| Revenue | ||||
| Consensus | $37.3M | $40.0M | — | — |
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q2 | Aug 5, 2026 | $0.25 | $0.14 | 78.6 % |
| Q1 | May 6, 2026 | $0.18 | $0.08 | 125.0 % |
| Q4 | Mar 9, 2026 | $0.19 | $0.05 | 280.0 % |
| Q3 | Nov 5, 2025 | $-0.01 | $-0.03 | 66.7 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q2 | Aug 5, 2026 | $39.66M | $33.57M | 18.1 % |
| Q1 | May 6, 2026 | $36.22M | $31.84M | 13.8 % |
| Q4 | Mar 9, 2026 | $34.13M | $28.00M | 21.9 % |
| Q3 | Nov 5, 2025 | $26.06M | $26.60M | -2.01 % |
